Finance

Lists
Why is ANL down 2.84%?
Dive Deeper
ANL:NASDAQ
Adlai Nortye Group Ltd
$14.05
-2.84%
(-0.41) 1D
Oct 7, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANL...
Open
$14.41
High
$15.04
Low
$14.03
Mkt. cap
984.36M
Avg. vol.
158.94K
Volume
0.00
52-wk high
$17.25
52-wk low
$0.88
EPS
-$0.65
Beta
1.13
Shares outstanding
72.86M
No. of employees
109
Open
$14.41
High
$15.04
Low
$14.03
Mkt. cap
984.36M
Avg. vol.
158.94K
Volume
0.00
52-wk high
$17.25
52-wk low
$0.88
EPS
-$0.65
Beta
1.13
Shares outstanding
72.86M
No. of employees
109
News stories
From web sources and news partners
About Adlai Nortye Group Ltd
CEO-
Employees109
Founded2004
Headquarters-
SectorBiotechnology
Websiteadlainortye.com
Analyst ratings
Based on 6 analysts giving stock ratings to ANL in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for ANL in the last 3 months.
Highest
Current $14.05
$49.00 (+248.75%)
Average
$30.80 (+119.22%)
Lowest
$20.00 (+42.35%)
Analyst
Recommendation
Action
Price target
Projected
Date
Maury Raycroft
Jefferies
Buy
Initiated
$31.00
+120.6%
09/10/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
$20.00
+42.3%
09/08/2026
Dev Prasad
Lucid Capital
Buy
Initiated
$49.00
+248.8%
09/08/2026
Jay Olson
Oppenheimer
Buy
Reiterated
$32.00
+127.8%
08/27/2026
Boris Peaker
JonesTrading
Buy
Maintained
$22.00
+56.6%
08/14/2026
Lina Kaminski
JonesTrading
Buy
Maintained
$22.00
+56.6%
07/16/2026
Li Watsek
Cantor Fitzgerald
Buy
Maintained
-
-
07/16/2026
David Siffringer
Cantor Fitzgerald
Buy
Initiated
$28.00
+99.3%
06/22/2026
Andrew Berens
Leerink Partners
Buy
Initiated
$23.00
+63.7%
03/20/2026
Christopher Liu
Lucid Capital
Buy
Initiated
$11.00
-21.7%
01/29/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.50M
2.50M
6.53M
6.53M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
8.79M
8.79M
7.32M
7.32M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.10M
2.10M
2.91M
2.91M
Operating expense
10.76M
10.76M
9.41M
9.41M
Total operating expenses
10.76M
10.76M
9.41M
9.41M
Operating income
-8.26M
-8.26M
-2.88M
-2.88M
Other non operating income
99.50K
99.50K
459.50K
459.50K
EBT including unusual items
-8.60M
-8.60M
-2.67M
-2.67M
EBT excluding unusual items
-8.60M
-8.60M
-2.67M
-2.67M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-128.00K
-128.00K
-812.00K
-812.00K
Net income
-8.60M
-8.60M
-2.67M
-2.67M
Net profit margin
-343.86%
-343.86%
-40.87%
-40.87%
Earnings per share
-
-
-
-
Interest and investment income
-
-
1.00K
1.00K
Interest expense
-434.50K
-434.50K
-222.50K
-222.50K
Net interest expenses
-434.50K
-434.50K
-221.50K
-221.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.01M
-8.07M
-2.69M
-2.69M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps